ACCF/AHA clopidogrel clinical alert: approaches to the FDA “Boxed Warning” a report of the american college of cardiology foundation task force on clinical expert …
Writing Committee Members, DR Holmes Jr… - Circulation, 2010 - Am Heart Assoc
ciation (AHA) convened a writing committee. The ACCF and AHA adhere to a rigorous policy
regarding relationships with industry and other entities (RWI) of authors and peer reviewers …
regarding relationships with industry and other entities (RWI) of authors and peer reviewers …
Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a …
A Bellemain-Appaix, SA O'Connor, J Silvain… - Jama, 2012 - jamanetwork.com
Context Clopidogrel pretreatment is recommended for patients with acute coronary
syndromes (ACS) and stable coronary artery disease who are scheduled for percutaneous …
syndromes (ACS) and stable coronary artery disease who are scheduled for percutaneous …
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from …
Platelet reactivity predicts ischemic outcomes in patients who undergo percutaneous
coronary intervention (PCI), but the correlation of heightened platelet response with …
coronary intervention (PCI), but the correlation of heightened platelet response with …
Outcome comparison of 600-and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation …
Objectives: The purpose of this study was to compare 600-and 300-mg clopidogrel loading
doses in patients with ST-segment elevation myocardial infarction (STEMI). Background …
doses in patients with ST-segment elevation myocardial infarction (STEMI). Background …
[PDF][PDF] 替格瑞洛与氯吡格雷对急性冠脉综合征患者经皮冠脉动脉介入术后血小板抑制效果的比较
李晶晶， 陈逸伦， 马永东， 高洁， 耿晓雯… - 现代生物医学 …, 2015 - biomed.cnjournals.com
摘要目的: 比较替格瑞洛与氯吡格雷对急性冠脉综合征(ACS) 患者经皮冠脉动脉介入术(PCI)
后血小板的抑制效果. 方法: 选择2014 年3 月至8 月在我院经替格瑞洛联合阿司匹林治疗的ACS …
后血小板的抑制效果. 方法: 选择2014 年3 月至8 月在我院经替格瑞洛联合阿司匹林治疗的ACS …
[HTML][HTML] Genetic polymorphism of CYP2C19 and inhibitory effects of ticagrelor and clopidogrel towards post-percutaneous coronary intervention (PCI) platelet …
P Dong, X Yang, S Bian - Medical science monitor: international …, 2016 - ncbi.nlm.nih.gov
Background The aim of this study was to observe the effects of genetic polymorphism of
CYP2C19 on inhibitory effects of ticagrelor (Tic) and clopidogrel (Clo) towards post …
CYP2C19 on inhibitory effects of ticagrelor (Tic) and clopidogrel (Clo) towards post …
Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a …
SJ Kim, W Kim, JS Woo, SJ Ha, WY Kang… - International journal of …, 2012 - Elsevier
BACKGROUND: Several studies have demonstrated that adenosine and nicorandil protect
the myocardium against angioplasty-related myocardial injury. We conducted a prospective …
the myocardium against angioplasty-related myocardial injury. We conducted a prospective …
Antiplatelet management for coronary heart disease: advances and challenges
M Gillette, K Morneau, V Hoang, S Virani… - Current atherosclerosis …, 2016 - Springer
Coronary heart disease (CHD) remains the leading cause of death in the USA. CHD
accounts for 48% of all cardiovascular mortality or approximately one of every seven deaths …
accounts for 48% of all cardiovascular mortality or approximately one of every seven deaths …
Platelet function and inhibition in ischemic heart disease
A Nusca, G Patti - Current cardiology reports, 2012 - Springer
Platelets play an important role in the pathogenesis of thrombosis, the most common cause
for the development of acute coronary syndromes such as complications occurring during …
for the development of acute coronary syndromes such as complications occurring during …
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from …
Whether an additional clopidogrel load in patients receiving chronic clopidogrel therapy and
undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) is …
undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) is …